Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

206.14 USD +3.79 (+1.87%)
Official Closing Price Updated: 7:58 PM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Eli Lilly

< Previous 1 2
...
93 94 95 96 97 98 99 100 Next >
Healthcare Sector Earnings: Making A Comeback In Q1 2017?
In 2016, healthcare was the only sector in the S&P 500 (SPX) that ended the year in the red, declining 2.7% versus a positive 12% ... 
Tags Markets PFE Analyst Color
From Benzinga
9 Blockbuster Drugs Making Their Debut In 2017; Total Revenue Expected To Be $16B By 2021
It is always interesting to see what analysts believe the big new drugs of the year are going to be worth 5 years down the road and Clarivate Analytics has listed the 9 blockbusters their analysts... 
Tags Stocks / Equities Healthcare
From Blogs - TalkMarkets
Eli Lilly Targets Hiked By Analysts Bullish On New Drugs
JPMorgan raised its price target on Eli Lilly to $100 from $85, as the firm believes that the company is "well-positioned for sustained growth" given the firm's positive outlook on the company's newer... 
Tags Stocks / Equities Healthcare
From Blogs - TalkMarkets
PRESS DIGEST - Wall Street Journal - April 11
April 11 (Reuters) - The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy. 
Tags companyNews
From Reuters: Company News
Biotechs Split: Axovant Rides CEO Swap, But Celgene Partner Dives
Axovant and OncoMed split the biotech sector Monday as Axovant stock popped on its CEO swap and OncoMed stock toppled on a failed drug trial. 
Tags Technology
From Investor's Business Daily
XLV, LLY, ABT, AET: ETF Inflow Alert
Symbols mentioned in this story: XLV, LLY, ABT, AET Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... 
Tags ETFs
From ETF Channel
5 Pharmaceutical Stocks With the Most Reliable Dividends
Tags ABBV JNJ NVO
From Motley Fool
FDA Warns Of Dangerous Hidden Ingredient In 5 OTC Male Sexual Enhancement Supplements
The U.S. Food and Drug Administration has issued a series of warnings about a handful of over-the-counter male sexual enhancement ... 
Tags Benzinga Cialis LLY
From Benzinga
Boehringer eyes marked sales gain, boosted by animal health
INGELHEIM, Germany, April 5 (Reuters) - Boehringer Ingelheim, Germany's second-largest drugmaker, said on Wednesday it was targeting a marked gain in 2017 revenues, boosted by new animal health... 
Tags companyNews
From Reuters: Company News
Eli Lilly (LLY) Breaks Through Resistance at $84.82
Shares of Eli Lilly (NYSE:LLY) have bullishly opened above the pivot of $84.44 today and have reached the first resistance level of $84.82. Investors may be interested in a... 
From Comtex SmarTrend® News Briefs
4 Drug Stocks With Big News Coming in April
Tags BMRN INCY LLY
From Motley Fool
Will Trump's FDA Chill Innovation Or Kill 'Astronomical' Prices?
It seems clear President Trump wants a leaner and meaner Food and Drug Administration, but how lean and how mean? 
Tags Technology
From Investor's Business Daily
BRIEF-Eli Lilly says Lilly Endowment Inc reports open market sale of 210,000 of stock
* Lilly Endowment Inc reports open market sale of 210,000 of co's common stock on march 30 at $84.674 per share - SEC filing Source text (http://bit.ly/2nrnkag) Further company coverage: 
Tags companyNews
From Reuters: Company News
Here's Why Halozyme Therapeutics, Inc Is Falling
Tags CELG HALO LLY
From Motley Fool
Interesting LLY Put And Call Options For May 12th
Investors in Lilly (Eli) & Co (LLY) saw new options begin trading today, for the May 12th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the LLY options chain for... 
Tags Stocks
From Market News Video
'Legislative risk' on drug prices is greater now, Citi says
Drugmakers may soon face renewed pressure on high prices, now that Republicans have pulled their American Health Care Act, Citi says. 
Tags Places/North America/United States GlaxoSmithKline PLC Eli Lilly and Co
From CNBC.com News
Noteworthy ETF Outflows: IYH, MDT, LLY, ABT
Symbols mentioned in this story: IYH, MDT, LLY, ABT Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... 
Tags ETFs
From ETF Channel
BRIEF-Intelgenx Technologies says Eli Lilly granted Versafilm exclusive license for tadalafil film product under erectile dysfunction dosing patent
* Intelgenx Technologies- Eli Lilly granted Intelgenx' Versafilm exclusive license for tadalafil film product under erectile dysfunction dosing patent 
Tags companyNews
From Reuters: Company News
LPC: Top US firms raise loans on tax reform hopes
NEW YORK, March 24 (Reuters) - Top US companies are raising 364-day syndicated loans to keep financial flexibility while they wait for details of a proposed tax windfall as the Trump administration... 
Tags companyNews
From Reuters: Company News
UPDATE 1-Drugmaker Lilly to invest $850 mln in U.S. operations in 2017
March 24 (Reuters) - Eli Lilly and Co said on Friday it would invest $850 million in its U.S. operations this year, and the drugmaker signaled it would be willing to spend more if the Trump... 
Tags companyNews
From Reuters: Company News
BRIEF-Eli Lilly announces $850 mln investment in U.S. capital projects in 2017
* Lilly announces $850 million investment in U.S. capital projects in 2017 
Tags companyNews
From Reuters: Company News
Drugmaker Lilly to invest $850 mln in U.S. operations in 2017
March 24 (Reuters) - Eli Lilly and Co said on Friday it would invest $850 million in its U.S. operations this year. 
Tags companyNews
From Reuters: Company News
Cramer's best and worst case scenarios for the health-care vote
Jim Cramer sees opportunity whichever way the Obamacare vote swings. 
Tags Investing/Indexes/S&P 500 Investing/Stock Market Investing
From CNBC.com News
BRIEF-Ignyta to explore strategic options for Taladegib through amendment of Taladegib license agreement with Lilly
* Ignyta announces exploration of strategic options for Taladegib, enabled by amendment of Taladegib license agreement with Lilly 
Tags companyNews
From Reuters: Company News
Novartis Leadership In Psoriasis Therapies Could Be Consolidated With New Drug "Cosentyx"
The pharma giant Novartis is looking to consolidate its hold on the lead role for new therapies for psoriasis with some remarkable data suggesting the drug could act as a disease modifier for a... 
Tags Stocks / Equities Healthcare
From Blogs - TalkMarkets
Gotham Index "Plus": A Better Way To Invest?
I am buying an index fund – with an important twist. This twist is brought to us by the Dynamic Duo of Joel Greenblatt and Robert Goldstein 
Tags Mutual Funds
From Blogs - TalkMarkets
Competition Increases Between Novartis, Lilly & Pfizer For Approval Of New Breast Cancer Drug
Just one week after Novartis scored a key approval for its CDK 4/6 cancer drug, Eli Lilly & Co. has announced that its long-awaited Phase III readout for its rival drug "abemaciclib" looks good albeit... 
Tags Healthcare Pharma/Biotech Stocks / Equities
From Blogs - TalkMarkets
Why Amgen's Success Was a Big Disappointment
Tags NVS LLY AMGN
From Motley Fool
BRIEF-Eli Lilly and Co says CEO John Lechleiter's 2016 total compensation was $18.4 mln
* CEO John C. Lechleiter's 2016 total compensation was $18.4 million versus $16.6 million in 2015 
Tags companyNews
From Reuters: Company News
UPDATE 3-Lilly's breast cancer drug combination succeeds key study
* To submit marketing application for mono, combo therapy in 2017 
Tags companyNews
From Reuters: Company News
< Previous 1 2
...
93 94 95 96 97 98 99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.